NDC 24979-715
Sorafenib
Sorafenib
Sorafenib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Twi Pharmaceuticals Usa, Inc.. The primary component is Sorafenib.
| Product ID | 24979-715_10f5b7bf-4e3b-48ef-8d95-dd13e902ad6d |
| NDC | 24979-715 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sorafenib |
| Generic Name | Sorafenib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-12-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA209050 |
| Labeler Name | TWi Pharmaceuticals USA, Inc. |
| Substance Name | SORAFENIB |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |